House Votes to Disapprove Medicaid Block Grant Guidance; Concerns Persist About Access Issues
The House of Representatives cast a vote of disapproval of guidance that would fundamentally alter the Medicaid program.
The House of Representatives cast a vote of disapproval of guidance that would fundamentally alter the Medicaid program.
Cancer patients, survivors and caregivers will tune into the president’s State of the Union address tonight, watching to see if the president will commit to improving the nation’s health care system by preserving access to comprehensive and affordable health care coverage.
Today the Centers for Medicare and Medicaid Services (CMS) announced guidance that would fundamentally alter the Medicaid program.
BOSTON – Gov. Charlie Baker has officially proclaimed January “Cervical Cancer Awareness Month” in Massachusetts.
Patient and health advocacy groups representing millions of Americans with pre-existing conditions are disappointed over the U.S. Supreme Court’s decision today not to immediately take up the case of Texas v. United States.
Patient and health advocacy groups representing millions of Americans with pre-existing conditions filed an amicus curiae or friend of the court brief today urging the U.S. Supreme Court to immediately take up the case of Texas v. United States. The case is the latest court challenge to the health care law known as the Affordable Care Act.
Nashville, TN – As lawmakers dive into the new year, the American Cancer Society Cancer Action Network (ACS CAN) is asking that legislators support legislation that will ease the burden of cancer in Tennessee.
Seventeen of the nation’s leading patient advocacy groups are remaining steadfast in their commitment to protecting patients throughout the next phase of legal proceedings involving the health care law known as the Affordable Care Act.
Congress is poised to pass a funding bill this week that includes a $2.6 billion increase for medical research at the National Institutes of Health (NIH). The measure, agreed upon by both House and Senate conference committee members, also provides $296 million increase for the National Cancer Institute (NCI).
The U.S. House will vote today on a bill intended to bring down patient prescription drug costs. Several of the bill’s provisions are important to cancer care, including establishing an annual cap on Medicare enrollees’ out-of-pocket expenses, allowing some Medicare beneficiaries to spread out high-cost prescription cost-sharing over the course of the year, and expanding Medicare eligibility for low-income subsidies.